- Barrons.com•22 hours ago
Yesterday, Gilead Sciences (GILD) announced better-than-forecast earnings but full-year sales guidance that fell short of analyst predictions, causing its shares to tumble. As result, expectations for ...
We keep the tough going with 2,300 convenient locations, 6,500 helpful employees & a 97% customer satisfaction rating. Talk about strength in numbers.
- Zacks•2 days ago
Medical stocks are once again expected be among the better performers in Q2. Johnson & Johnson (JNJ) and Biogen have already set the tone with beats and raised outlooks.
After hours: 63.270.63 (1.01%) as of 6:33 PM EDT
|Bid||55.20 x 100|
|Ask||65.45 x 100|
|52wk Range||26.41 - 63.35|
|Day's Range||62.35 - 63.20|
|Avg Vol (3m)||2,749,179|
As of 4:00 PM EDT. Market closed.